Skip NavigationSkip to Content

Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of Simian immunodeficiency virus

  1. Author:
    Simpson, Jennifer
    Starke, Carly E
    Ortiz, Alexandra M
    Ransier, Amy
    Darko, Sam
    Llewellyn-Lacey, Sian
    Fennessey,Christine
    Keele,Brandon
    Douek, Daniel C
    Price, David A
    Brenchley, Jason M
  2. Author Address

    Barrier Immunity Section, National Institutes of Health, Bethesda, United States of America., Human Immunology Section, National Institutes of Health, Bethesda, United States of America., Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., AIDS and Cancer Virus Program, National Institutes of Health, Frederick, United States of America.,
    1. Year: 2024
    2. Date: Jun 11
    3. Epub Date: 2024 06 11
  1. Journal: JCI Insight
  2. Type of Article: Article
  3. Article Number: e174168
  1. Abstract:

    Antibody-mediated depletion studies have demonstrated that CD8+ T cells are required for effective immune control of SIV. However, this approach is confounded by several factors, including reactive CD4+ T cell proliferation, and further provides no specificity information. We circumvented these limitations by selectively depleting CD8+ T cells specific for the Gag epitope CTPYDINQM (CM9) via the administration of immunotoxin-conjugated tetrameric complexes of CM9/Mamu-A*01. Immunotoxin administration effectively depleted circulating but not tissuelocalized CM9-specific CD8+ T cells, akin to the bulk depletion pattern observed with antibodies directed against CD8. However, we found no evidence to indicate that circulating CM9-specific CD8+ T cells suppressed viral replication in Mamu-A*01+ rhesus macaques during acute or chronic progressive infection with a pathogenic strain of SIV. This observation extended to macaques with established infection during and after continuous antiretroviral therapy. In contrast, natural controller macaques experienced dramatic increases in plasma viremia after immunotoxin administration, highlighting the importance of CD8+ T cell-mediated immunity against CM9. Collectively, these data showed that CM9-specific CD8+ T cells were necessary but not sufficient for robust immune control of SIV in a nonhuman primate model and, more generally, validated an approach that could inform the design of next-generation vaccines against HIV-1.

    See More

External Sources

  1. DOI: 10.1172/jci.insight.174168
  2. PMID: 38885329
  3. PII : 174168

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel